Huang YM, Xu B, Kuai Z, et al
Both are part of a booming class of medications often grouped under the umbrella of GLP-1 drugs, which roughly 12% of Americans including about 1 in 5 women over 50 have used for weight loss or diabetes management
63 Proteomic analyses further suggest selective depletion of C-terminal degrons in eukaryotic proteins, supporting the existence of C-end rules that shape proteome composition
However, both medications require a titration period where the dose is slowly increased over several weeks to minimize side effects, so initial results are usually gradual for both
The trends observed across both studies consistently showed more responders in the bremelanotide group for secondary measures involving desire, arousal, and satisfaction [1]
Im happy there are no side effects